Research Interests
Postoperative pain
Persistent pain
Enhanced Recovery after Surgery
Postoperative nausea and vomiting
High-risk pregnancy
Placenta accreta spectrum
Persistent pain
Enhanced Recovery after Surgery
Postoperative nausea and vomiting
High-risk pregnancy
Placenta accreta spectrum
Selected Grants
Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
ResearchCollaborating Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2030Vanderbilt Agreement_Premier Study
ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2026 - 2027A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Laparoscopic Procedures of the Intraperitoneal or Retroperitoneal Cavities or Arthroscopic Orthopedic Pr
Clinical TrialPrincipal Investigator · Awarded by Vertex Pharmaceuticals Inc. · 2025 - 2026Integrated Training in Anesthesiology Research
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 1996 - 2026Rectus Sheath Block with liposomal bupivacaine for postoperative analgesia following gynecologic oncology surgery: A pilot Study
Clinical TrialPrincipal Investigator · Awarded by Pacira BioSciences, Inc. · 2024 - 2026A Global Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery
Clinical TrialPrincipal Investigator · Awarded by Haisco-USA Pharmaceuticals, Inc. · 2024 - 2025Pacira IIT
Clinical TrialPrincipal Investigator · Awarded by Pacira BioSciences, Inc. · 2023 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery
Clinical TrialPrincipal Investigator · Awarded by Haisco-USA Pharmaceuticals, Inc. · 2022 - 2024Cardiovascular Risk Prediction for Improved Maternal Health
ResearchCo-Mentor · Awarded by Foundation for Anesthesia Education and Research · 2022 - 2023A Phase 2 Open-Label Study of the Pharmacokinetics and Safety of HTX-011 Administered Postpartum to Women Undergoing a Planned Caesarean Section)
Clinical TrialPrincipal Investigator · Awarded by Heron Therapeutics, Inc. · 2021 - 2022A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis
Clinical TrialPrincipal Investigator · Awarded by Heron Therapeutics, Inc. · 2021 - 2022402-C-414 Exparel versus SOC in CS
Clinical TrialPrincipal Investigator · Awarded by Pacira Pharmaceuticals · 2019 - 2021Obstructive Sleep Apnea Screening in Pregnant Women with Chronic Hypertension
ResearchSignificant Contributor · Awarded by Society for Obstetric Anesthesia and Perinatology · 2017 - 2020A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Safety and Efficacy of EXPAREL When Administered via Infiltration into the Transversus Abdominis Plane (TAP) Versus Bupivacaine Alone in Subjects Undergoing Elective Ces
Clinical TrialPrincipal Investigator · Awarded by Pacira Pharmaceuticals · 2017 - 2019BioQ Ropivacaine 0.2% Pre-Filled Dispenser for Post op Pain after CS
Clinical TrialPrincipal Investigator · Awarded by BioQ Pharma · 2017 - 2019Trevena Oliceridine for acute pain
Clinical TrialPrincipal Investigator · Awarded by Trevena, Inc. · 2016 - 2018Randomised, double-blind, placebo-controlled study of APD421 (amisulpride for IV injection) as treatment of established post-operative nausea and vomiting, in patients who have had prior prophylaxis
Clinical TrialPrincipal Investigator · Awarded by Acacia Pharma · 2016 - 2018Pregabalin for PDPH
Clinical TrialPrincipal Investigator · Awarded by King Edward Memorial Hospital · 2017 - 2018DP10017-Randomized, double-blind, placebo-controlled Phase III study of APD421 (amisulpride for IV injection) as combination prophylaxis against post-operative nausea and vomiting in high-risk patient
Clinical TrialPrincipal Investigator · Awarded by Premier Research · 2015 - 2018DP10018 - Randomised, double-blind, placebo-controlled study of APD421 (amisulpride for IV injection) as treatment of established post-operative nausea and vomiting, in patients who have had no prior prophylaxis
Clinical TrialPrincipal Investigator · Awarded by Acacia Pharma · 2015 - 2017Forgetting to remember: Prospective memory error as an unexplored patient safety risk
ResearchCo Investigator · Awarded by Anesthesia Patient Safety Foundation · 2013 - 2015External Relationships
- International Anesthesia Research Society
- Orion
- Vertex Pharmaceuticals Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.